SLDB FY 2017 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena

SLDBSolid Biosciences Inc.

$581M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$448,000

Operating Income

-$55M

Net Income

-$52M

EPS (Diluted)

$-24.26

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$46M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$76M

Total Liabilities

$135M

Stockholders' Equity

-$59M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$448,000	-$56,000	-700.0%
Operating Income	-$55M	-$26M	-114.5%
Net Income	-$52M	-$22M	-142.0%